EXAS - EXACT SCIENCES CORP

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 61.23

Open

$ 61.31

Bid

$ 60.50 x 10

Ask

$ 62.39 x 1

Day's Range

$ 60.90 - $ 62.11

52 Week Range

$ 38.81 - $ 72.83

Volume

2,152,038

Average Volume

Market Cap

11.59B

Beta (5Y Monthly)

$ 1.15

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2025	06-30-2025	10-Q
2	05-01-2025	03-31-2025	10-Q
3	02-19-2025	12-31-2024	10-K
4	11-05-2024	09-30-2024	10-Q
5	07-31-2024	06-30-2024	10-Q
6	05-08-2024	03-31-2024	10-Q
7	02-21-2024	12-31-2023	10-K
8	11-01-2023	09-30-2023	10-Q
9	08-01-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	02-21-2023	12-31-2022	10-K
12	11-03-2022	09-30-2022	10-Q
13	08-02-2022	06-30-2022	10-Q
14	04-26-2022	03-31-2022	10-Q
15	02-22-2022	12-31-2021	10-K
16	11-02-2021	09-30-2021	10-Q
17	07-28-2021	06-30-2021	10-Q
18	05-04-2021	03-31-2021	10-Q
19	02-16-2021	12-31-2020	10-K
20	10-27-2020	09-30-2020	10-Q
21	07-31-2020	06-30-2020	10-Q
22	05-06-2020	03-31-2020	10-Q
23	02-21-2020	12-31-2019	10-K
24	10-30-2019	09-30-2019	10-Q
25	07-30-2019	06-30-2019	10-Q
26	04-30-2019	03-31-2019	10-Q
27	02-21-2019	12-31-2018	10-K
28	10-30-2018	09-30-2018	10-Q
29	08-01-2018	06-30-2018	10-Q
30	04-26-2018	03-31-2018	10-Q
31	02-22-2018	12-31-2017	10-K
32	10-30-2017	09-30-2017	10-Q
33	07-25-2017	06-30-2017	10-Q
34	04-27-2017	03-31-2017	10-Q
35	02-21-2017	12-31-2016	10-K
36	10-26-2016	09-30-2016	10-Q
37	07-26-2016	06-30-2016	10-Q
38	05-03-2016	03-31-2016	10-Q
39	02-24-2016	12-31-2015	10-K
40	10-30-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Piper Sandler Maintains Overweight on Exac...
10/08/2025 12:40:35

Piper Sandler analyst David Westenberg maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target ...

Evercore ISI Group Maintains Outperform on...
10/07/2025 17:04:35

Evercore ISI Group analyst Vijay Kumar maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and raises the price target ...

Exact Sciences Announces Publication Of Co...
10/07/2025 11:00:29

What Analysts Are Saying About Exact Scien...
10/02/2025 19:01:38

Barclays Maintains Overweight on Exact Sci...
10/02/2025 13:56:58

Barclays analyst Luke Sergott maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target from $55 ...

Peering Into Exact Sciences's Recent Short...
09/18/2025 13:00:58

Demystifying Exact Sciences: Insights From...
09/11/2025 22:02:07

Craig-Hallum Maintains Buy on Exact Scienc...
09/11/2025 17:21:22

Craig-Hallum analyst Alex Nowark maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $65 to $85.

Exact Sciences Launches Cancerguard Test, ...
09/10/2025 10:40:51

Only MCED test on-market to analyze multiple biomarker classes, enhancing early cancer detectionOffered as a laboratory-develop...

wayfair-united-therapeutics-and-ciena-are-among-the-top-10-large-cap-gainers-last-week-sep-1-sep5-are-the-others-in-your-portfolio-corrected

Wayfair, United Therapeutics, And Ciena Ar...
09/07/2025 14:30:00

These ten large-cap stocks were top performers last week. Are they a part of your portfolio?

micron-to-rally-more-than-49-here-are-10-top-analyst-forecasts-for-tuesday

Micron To Rally More Than 49%? Here Are 10...
08/12/2025 19:13:44

BTIG Maintains Buy on Exact Sciences, Lowe...
08/12/2025 15:13:48

BTIG analyst Mark Massaro maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $65 to $60.

Beyond The Numbers: 7 Analysts Discuss Exa...
08/11/2025 13:02:28

Piper Sandler Maintains Overweight on Exac...
08/11/2025 12:18:12

Piper Sandler analyst David Westenberg maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and lowers the price target ...

top-3-health-care-stocks-that-are-preparing-to-pump-this-month

Top 3 Health Care Stocks That Are Preparin...
08/11/2025 12:01:23

Evercore ISI Group Maintains Outperform on...
08/08/2025 12:29:14

Evercore ISI Group analyst Vijay Kumar maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and lowers the price target ...

exact-sciences-dip-a-chance-to-buy-as-freenome-deal-fortifies-future-analyst

Exact Sciences Dip A Chance To Buy As Free...
08/07/2025 18:56:41

Exact Sciences beat Q2 expectations, raised its 2025 forecast, and secured U.S. rights to Freenome's CRC blood tests in a m...

UBS Maintains Neutral on Exact Sciences, L...
08/07/2025 17:28:15

UBS analyst Dan Leonard maintains Exact Sciences (NASDAQ:EXAS) with a Neutral and lowers the price target from $61 to $53.

RBC Capital Maintains Sector Perform on Ex...
08/07/2025 14:56:24

RBC Capital analyst Conor McNamara maintains Exact Sciences (NASDAQ:EXAS) with a Sector Perform and lowers the price target ...

Barclays Maintains Overweight on Exact Sci...
08/07/2025 13:22:30

Barclays analyst Luke Sergott maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and lowers the price target from $65 ...